Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
01/04/2012 | EP2402309A1 CCR9 inhibitors and methods of use thereof |
01/04/2012 | EP2402300A1 Hydroxyl compounds and compositions for cholesterol management and related uses |
01/04/2012 | EP2401257A1 Enzyme inhibitors |
01/04/2012 | EP2401256A1 Compounds as bradykinin b1 antagonists |
01/04/2012 | EP2401253A2 A process for the preparation of etoricoxib |
01/04/2012 | EP2307370B1 Sulfoximinamide compounds for combating animal pests |
01/04/2012 | EP2297103B1 Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors |
01/04/2012 | CN1910166B Heteroaryl-ureas and their use as glucokinase activators |
01/04/2012 | CN102307872A BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
01/04/2012 | CN102307871A Isoindolinone and related analogs as sirtuin modulators |
01/04/2012 | CN102307860A GPR120 receptor agonists and uses thereof |
01/04/2012 | CN102307839A Method for producing aldehydes and ketones from primary and secondary alcohols |
01/04/2012 | CN102304110A Hydroxamates as therapeutic agents |
01/04/2012 | CN102304086A Heterocyclic inhibitors of MEK and methods of use thereof |
01/04/2012 | CN102304085A Process for synthesizing trigonelline hydrochloride from dimethyl carbonate and nicotinic acid |
01/04/2012 | CN102304084A Method for preparing 2,6-diemthyl-3,5-binitropyridine |
01/04/2012 | CN102304083A Preparation method of 2-chloromethyl-3,4-dimethoxypyridine hydrochloride |
01/04/2012 | CN102304082A Synthesis method of 2-chloro-4-(piperidylmethyl)pyridine |
01/04/2012 | CN102304081A Green synthesis method for ibuprofen piconol and medicinal preparation thereof |
01/04/2012 | CN102304080A Method for preparing divinyl dipyridine compounds |
01/04/2012 | CN102304054A Chelate type ionic liquid and preparation and purification method thereof |
01/04/2012 | CN102070517B 6-methyl-2,3,5-pyridine tricarboxylic acid and synthetic method thereof |
01/04/2012 | CN101163678B Pyridylmethylsulfone derivative |
01/03/2012 | US8088926 Substituted 2-methyl-2-phenoxy-N-propyl-propionamides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity |
01/03/2012 | US8088924 Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor |
01/03/2012 | US8088921 Method for producing 3-amidinophenylalanine derivatives |
01/03/2012 | US8088802 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
01/03/2012 | US8088772 Sulfonamides and their use as a medicament |
01/03/2012 | CA2601508C Cyclopropanecarboxamide derivatives |
01/03/2012 | CA2536257C Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
01/03/2012 | CA2529464C Propionamide derivatives useful as androgen receptor modulators |
01/03/2012 | CA2517705C Method for labeling phosphorylated peptides, method for selectively adsorbing phosphorylated peptides, complex compounds used in the methods, process for producing the complex compounds, and raw material compounds for the complex compounds |
01/03/2012 | CA2484685C Optically active .beta.-aminoketones, optically active 1,3-amino alcohols and method for the production thereof |
01/03/2012 | CA2480356C Benzamide derivatives useful as histone deacetylase inhibitors |
01/03/2012 | CA2423220C Modified prodrug forms of ap/amp |
01/03/2012 | CA2397018C Compounds exhibiting thrombopoietin receptor agonism |
01/03/2012 | CA2381426C Metal complexes comprising a 2,6-diacylpyridine-ligand and their use in the polymerization of ethylene |
12/29/2011 | WO2011163610A2 Antimicrobial agents |
12/29/2011 | WO2011163469A1 Hydrated form of anti-inflammatory roflumilast-n-oxide |
12/29/2011 | WO2011161945A1 Alkoxyimino derivative and pest control agent |
12/29/2011 | WO2011161612A1 Process for preparing 4-hydroxypyridines |
12/29/2011 | WO2011161446A1 Compounds for treating proliferative disorders |
12/29/2011 | WO2011161201A1 Bisarylsulfonamides useful as kinase inhibitors in the treatment of inflammation and cancer |
12/29/2011 | WO2011092663A3 Sorafenib dimethyl sulphoxide solvate |
12/29/2011 | US20110319629 Titanium compounds and process for cyanation of imines |
12/29/2011 | US20110319628 One-pot process for the synthesis of dalfampridine |
12/29/2011 | US20110319627 METHODS OF SYNTHESIZING FACTOR Xa INHIBITORS |
12/29/2011 | US20110319616 Thiazole derivative and process for producing same |
12/29/2011 | US20110319454 Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity |
12/29/2011 | US20110319449 Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists |
12/29/2011 | US20110319445 Heteroaryl antagonists of prostaglandin d2 receptors |
12/29/2011 | US20110319438 Novel sulfonamides as l-cpt1 inhibitors |
12/29/2011 | US20110319437 Iminopropene compound and use thereof |
12/29/2011 | US20110319431 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
12/29/2011 | US20110319367 Phenazopyridine Compounds |
12/29/2011 | US20110319347 Antioxidant agent |
12/29/2011 | US20110318691 Resist composition for semiconductor, and resist film and pattern forming method using the same |
12/29/2011 | CA2803890A1 Antimicrobial agents |
12/29/2011 | CA2802952A1 Niacin mimetics, and methods of use thereof |
12/29/2011 | CA2802945A1 Niacin mimetics, and methods of use thereof |
12/28/2011 | EP2399903A1 Ccr9 inhibitors and methods of use thereof |
12/28/2011 | EP2398558A1 Amine or amino alcohols as glyt1 inhibitors |
12/28/2011 | EP1999109B1 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques |
12/28/2011 | EP1922307B1 Heterocyclic inhibitors of mek and methods of use thereof |
12/28/2011 | EP1158985B1 OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS |
12/28/2011 | CN102300846A 用于标记正电子发射同位素的三芳基锍化合物、药盒和方法 For labeling n triaryl sulfonium compounds, kits and methods of the electron-emitting isotopes |
12/28/2011 | CN102300844A 作为抗疟剂的氨磺酰基-苯基-脲基苯甲脒衍生物 As antimalarial agent sulfamoyl - phenyl - ureido benzamidine derivatives |
12/28/2011 | CN102295663A 一种双负离子胍基稀土锂配合物及其应用 A two anion guanidine RE lithium complex and its application |
12/28/2011 | CN102295599A 一种烟酸的生产方法及制粒方法 One kind of niacin production methods and granulation process |
12/28/2011 | CN102295598A 一种维生素B<sub>6</sub>的结晶方法 A vitamin B <sub> 6 </ sub> crystallization method |
12/28/2011 | CN102295597A 三氯吡氧乙酸丁氧基乙酯的制备方法 Triclopyr butoxy ethyl acetate preparation |
12/28/2011 | CN102295596A 一种2,2'-联吡啶-4,4'-二甲醛的合成方法 One kind of 2,2'-bipyridine-4,4'-synthesis of formaldehyde |
12/28/2011 | CN102295595A 一种生产吡啶化合物的方法 The method for producing a pyridine compound |
12/28/2011 | CN101875666B 光学纯1, 3-氨基醇类化合物、制备方法以及在制备达泊西汀及其类似物中的用途 Optically pure 1, 3-amino alcohol compounds, preparation and use in the manufacture of dapoxetine and the like in |
12/28/2011 | CN101781265B 氨基酸与农药的藕合物及其制备方法与作为农药的应用 Amino acids coupled with the pesticide and its preparation method and use as pesticides |
12/28/2011 | CN101613315B 环金属铂配合物液晶偏振发光材料及其应用 Ring platinum complexes LCD polarizing light-emitting materials and their applications |
12/28/2011 | CN101415682B 被取代的烯氨羰基化合物 Substituted alkenyl aminocarbonyl compound |
12/28/2011 | CN101379034B 作为cetp抑制剂的苯甲酰胺和杂芳烃衍生物 As cetp inhibitors benzamide derivatives and heteroarene |
12/28/2011 | CN101205202B 取代苯基脲类化合物及其制备与应用 Substituted compounds and their preparation and application Phenylurea |
12/27/2011 | US8084645 4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors |
12/27/2011 | US8084616 TRPV1 antagonists |
12/27/2011 | US8084615 Antibacterial agents |
12/27/2011 | US8084614 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
12/27/2011 | US8084610 Compositions and methods for detecting and treating tumors containing acidic areas |
12/27/2011 | US8084607 Apoptosis promoters |
12/27/2011 | US8084503 Indene derivatives as pharmaceutical agents |
12/27/2011 | US8084476 Substituted methyl aryl or heteroaryl amide compounds |
12/27/2011 | US8084471 Proteomimetic compounds as inhibitors of the interaction of nuclear receptor with coactivator peptides |
12/27/2011 | US8084465 Derivatives of pryidone and use thereof |
12/22/2011 | WO2011159840A2 Phenylthioacetate compounds, compositions and methods of use |
12/22/2011 | WO2011159839A2 Thioacetate compounds, compositions and methods of use |
12/22/2011 | WO2011159297A1 Gpr120 receptor agonists and uses thereof |
12/22/2011 | WO2011158250A1 Process for preparation of 2, 3-diaryl-5-substituted pyridines and their intermediates |
12/22/2011 | WO2011158189A1 X-ray and gamma-photon activable organic compounds, their preparation and their uses |
12/22/2011 | WO2011158058A1 α-CRYSTALLINE FORM OF CARBABENZPYRIDE |
12/22/2011 | WO2011157779A1 Organic electronic devices comprising a layer of a pyridine compound and a 8-hydroxyquinolinolato earth alkaline metal, or alkali metal complex |
12/22/2011 | WO2011157743A1 Alpha-crystalline form of carbabenzpyride |
12/22/2011 | WO2011157650A1 Process for preparing 2,2-difluoroethylamine derivatives by alkylation with 2,2-difluoro-1-haloethanes |
12/22/2011 | WO2010145764A8 Substituted enamino carbonyl compounds |
12/22/2011 | US20110313168 Method for preparing activated esters |